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Abstract
Purpose The general consensus that tendinopathy, at
least in the chronic stage, is mainly a degenerative condi-
tion and inflammation plays a minor role has led to a shift
from treatments that target inflammation towards treatment
options that promote regeneration. One of these treatments
is extracorporeal shockwave therapy (ESWT), a physical
therapy modality that uses pressure waves to treat tendin-
opathy. This review was undertaken to give an overview of
the literature concerning this treatment, and special atten-
tion is given to the differences between focused and radial
ESWT.
Methods A narrative description of wave characteristics,
generation methods and in vitro effects of ESWT is given.
The literature on ESWT as a treatment for one common
tendinopathy, patellar tendinopathy, was systematically
reviewed.
Results Waves that are generated for focused and radial
ESWT have very different physical characteristics. It is
unclear how these characteristics are related to clinical
effectiveness. Studies into the biological effects of ESWT
have mainly used focused shockwave therapy, showing a
number of effects of shockwaves on biological tissue. The
systematic review of studies into the clinical effects of
ESWT for patellar tendinopathy showed conflicting evi-
dence for its effectiveness.
Conclusion Physical characteristics of focused and radial
waves differ substantially, but effect on clinical effective-
ness is unclear. Whereas in vitro studies often show the
effects of ESWT on tendon tissue, results of clinical studies
are inconsistent. Based on the review of the literature,
suggestions are given for the use of ESWT in clinical
practice regarding timing and treatment parameters.
Level of evidence IV.
Keywords Tendinopathy  Shockwave  Treatment
Introduction
Tendon injuries (tendinopathies) are common in the entire
population, especially in relation to sports and occupation
[45, 46]. Tendinopathy has a complex pathophysiology. It
consists of a short acute inflammatory stage but after
some time, it gradually becomes a degenerative condition
[1].
Because both conservative and surgical management of
tendinopathy is not always successful, new treatment
modalities have been developed. One of these modalities is
extracorporeal shockwave therapy (ESWT). In 2002,
Chung and Wiley [8] published a review about ESWT for
treating tendinopathies. At that time, they concluded based
on the literature that there was strong evidence for the
effectiveness of ESWT for chronic tendinopathy and that
further research was required to settle debates concerning
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applied energy, number of pulses and number of treatment
sessions.
Over the last decade, next to increased knowledge about
the pathogenesis of tendinopathy, there have been technical
developments and an accumulation of studies examining
the working mechanisms of ESWT and its effectiveness.
One of the main technical developments is that nowadays
two different kinds of ESWT are used for treating tendin-
opathy: focused ESWT (FSWT) and radial ESWT
(RSWT). RSWT is relatively new and has made ESWT
more affordable and more widely available. These new
technologies are the rationale for this review. Most
research has been done using FSWT, but research on
RSWT is starting to be published. The aim of the present
review is to give an up-to-date description of ESWT, with a
special focus on differences between FSWT and RSWT,
and review the literature about this treatment method. The
overview consists of a description of wave characteristics,
methods to generate shockwaves, and in vitro and clinical
effects of ESWT, the latter by performing a systematic
review with methodological quality assessment on the
effects of ESWT for patellar tendinopathy, as an example
of a common tendinopathy.
Pressure waves
Pressure waves (or sound waves) are oscillating mechani-
cal waves that can travel through gas, liquids and solids. A
shockwave is a special, non-linear type of pressure wave
(Fig. 1), characterized by a short rise time. The total
duration of a shockwave is around 10 ls [10, 42].
Both the positive and the negative phase of a shockwave
have an effect on interfaces between tissues with different
density (acoustic impedance). During the positive phase,
shockwaves with high pressure may hit an interface,
leading to reflections, or they may pass and gradually
become absorbed. The negative (tensile) phase of the
shockwave causes cavitation at the tissue interfaces. Dur-
ing cavitation, air bubbles are formed as a result of the
negative pressure. These bubbles subsequently implode
with high speed, generating a second wave of shockwaves
or micro-jets of fluid [10, 42].
Types of ESWT
There are two types of shockwave therapy: focused
shockwave therapy (FSWT) and radial shockwave therapy
(RSWT). This section will describe wave characteristics of
both methods.
FSWT
FSWT is called focused because a pressure field is gener-
ated that converges in the adjustable focus at selected depth
in the body tissues, where the maximal pressure is reached
(Fig. 2a). There are three methods to generate focused
shockwaves for FSWT: electrohydraulic (EH), electro-
magnetic (EM) and piezoelectric (PE) [42]. All three have
in common that the waves are generated in water (inside
the applicator). Focused shockwaves are generated in water
because the acoustic impedance of water and biologic tis-
sue is comparable. As a result of this, reflection is limited
and waves are better transferred into the body.
A difference between these three methods is the moment
at which the shockwave forms. EH generators produce
Fig. 1 Pressure–time profile of a shockwave (reprinted from [6])
Fig. 2 a Pressure field of a focused shockwave device (EH-generated
by means of spark gap). b Pressure field of a radial shockwave device
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focused shockwaves at origin, immediately after the spark
gap, while EM and PE generators form shockwaves
nanoseconds later by means of focusation of waves that are
generated [12].
RSWT
The term radial refers to the diverging pressure field of
RSWT devices, which reach a maximal pressure already at
the source (Fig. 2b), not at a selected depth in the body.
Radial shockwaves for RSWT are generated by accelerat-
ing a projectile, using compressed air, through a tube on the
end of which an applicator is placed. The projectile hits the
applicator and the applicator transmits the generated
pressure wave into the body. In contrast to focused shock-
wave, radial pressure waves are not generated in water.
FSWT versus RSWT
There are two important differences in wave characteristics
between focused shockwaves and radial shockwaves. First,
radial shockwaves have a more superficial effect, compared
to focused shockwaves, which reach a maximal energy in
the focus that is located deeper into the body tissues
(Fig. 2) [39]. It was shown that a RSWT device generates a
pressure field extending to 40 mm in water, whereas the
pressure field generated during FSWT may reach a distance
that is about twice as high [39]. How these measures relate
to biological tissue is not known. These measures are also
dependent of the device that is used and the energy setting.
In general, focused shockwaves will travel further and have
more impact on deeper located tissues.
Second, research has shown that pressure waves gener-
ated by RSWT from a fundamental point of view cannot be
called shockwaves because they lack the characteristic
physical features of shockwaves (Fig. 3) such as a short
rise time, a high peak pressure and non-linearity [11]. A
reason for this is that the speed of sound in tissue is around
1,500 m/s, whereas the projectile during radial pressure
wave generation can only reach a speed of around 20 m/s
[39]. This speed is not high enough to generate a real
shockwave. Chitniss and Cleveland [7] found that the rise
time (tr) of the generated wave was 25–40 ns for two
focused devices (EH), whereas it was 600 ns for a radial
shockwave device. Although 25–40 ns is longer than the
definition given above of a shockwave, the waves gener-
ated with the EH devices showed the features that are
typical for a shockwave (Fig. 1), whereas the wave gen-
erated with the radial device lacked these characteristics.
Based on these findings, it may be more correct to use the
term radial pressure wave therapy instead of RSWT.
Radial pressure wave devices also come with ‘focused’
applicators. However, Cleveland et al. [11] showed that
these applicators do not generate real shockwaves either.
Because it is not clear which wave characteristics gen-
erate therapeutic effects, it is difficult to relate physical
differences between focused shockwaves and radial pres-
sure waves to clinical effectiveness [9, 36].
Biological effects of ESWT—in vitro studies
Until now, most fundamental research on ESWT for ten-
dinopathy has been done with focused shockwaves. Fun-
damental research into the biological effects of ESWT has
been concentrated on a number of non-exclusive theories
about the working mechanisms of ESWT in tendinopathy.
These theories can be roughly divided into pain relief,
tissue regeneration and destruction of calcifications.
Pain relief
Pain relief with ESWT might work by means of hyper-
stimulation analgesia [40]. Overstimulation of the treated
site would lead to a diminished transmission of signals to
the brainstem [51]. Animal studies show that ESWT has an
influence on pain transmission by acting on substance P
[21, 37], calcitonin gene-related peptide (CGRP) expres-
sion in the dorsal root ganglion [52] and on neurovascular
sprouting [20], Haake et al. however found no effect of
ESWT on substance P and CGRP [18].
Tissue regeneration
A second theory is that ESWT stimulates tissue regenera-
tion. Tissue regeneration by means of ESWT does fit
within the framework of mechanotransduction, where
mechanical load on the cytoskeleton leads to cell responses
and increased protein synthesis [26]. Healthy human
tenocytes responded to ESWT with cell growth and
Fig. 3 Differences in pressure–time profile of a shockwave (gener-
ated with a focused shockwave device) and a pressure wave
(generated with a radial shockwave device) (reprinted from [39])
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increased collagen synthesis [55], mainly type-I, and in
affected human tenocytes, ESWT decreased the expression
of matrix metalloproteases (MMPs) and interleukins (ILs)
that are associated with tendinopathy [19]. Animal studies
show that ESWT leads to an increase in collagen produc-
tion and matrix turnover [3, 4, 23], increased vasculariza-
tion in the bone–tendon junction [57] and increased tissue
regeneration in wound healing and ischaemia [25, 31, 41].
Destruction of calcifications
Although in vitro studies are lacking, it is thought that
ESWT may also destroy calcifications in tendons. This
effect is comparable with the way shockwaves are used in
lithotripsy to destroy kidney stones. In vivo studies show
the disintegration of calcifications in shoulder tendinopathy
after ESWT [15, 44].
Clinical effects of ESWT
Although in vitro studies have demonstrated biological
effects of ESWT, clinical effects of ESWT are less clear.
In this section, we will focus on patellar tendinopathy, as
an example of a common sports injury for which ESWT
is increasingly used and which has the same underlying
pathology as other common (insertional) tendinopathies
[27]. A systematic search of the literature was performed
to identify randomized controlled trials (RCTs) that
studied the effectiveness of ESWT for patellar tendinop-
athy. The search was performed in the PubMed and
Embase database. Four RCTs were found in this search
[43, 53, 56, 58]. The methodological quality of the four
indentified studies was independently scored by two
authors (Henk van der Worp and Inge van den Akker-
Scheek) using the PEDro checklist [35]. Characteristics as
well as the PEDro score of the four included studies are
shown in Table 1.
From this table, it appears that, although in vitro studies
have demonstrated biological effects of ESWT, the clinical
effects of ESWT for the treatment of patellar tendinopathy
are less clear. Some studies found ESWT to be effective,
whereas in others there was no or little improvement.
Remarkably, the study that showed the largest improve-
ment was the only one without a placebo intervention [56].
Discussion
The most important finding of this review was that there is
conflicting evidence regarding the effectiveness of ESWT
for patellar tendinopathy. This conflicting evidence may
have several reasons. First, there is a lack of objective
diagnostic criteria for patellar tendinopathy. Second, it may
be that ESWT is only effective during certain stages of
tendinopathy and not during other stages. A third reason
may be that there are many instrumental settings—like
choice of generator (EH, EM or PE), focal depth, number
and intensity of pulses (energy flux density)—that can be
varied and which may play a role in the effectiveness. A
last reason is a methodological one.
These four topics will be described below. These topics
are also of importance for research into the effectiveness of
other tendinopathies where also conflicting results have
been shown [2, 5, 54].
Diagnosis
There is no gold standard for the diagnosis of tendinopathy.
This diagnosis is obtained from a combination of history of
symptoms and physical examination [14]. Imaging increases
the likelihood of a correct diagnosis, but is not conclusive.
The absence of a gold standard may result in non-uniform
populations in clinical studies.
Stage of tendinopathy
Effectiveness of ESWT may depend on the stage of ten-
dinopathy. A recent model of tendinopathy differentiates
between a reactive tendinopathy/early tendon disrepair
phase and a late tendon disrepair/degeneration phase [13].
ESWT seems most appropriate in the latter where the
tendinopathy is degenerative and when conservative treat-
ment has no effect [13, 45]. This is also supported by recent
studies that showed no effect of ESWT in the early stage of
tendinopathy [47, 58]. Until now, studies have not differ-
entiated between subjects in the study based on these dif-
ferent stages; therefore, different studies may have used
populations that are not comparable.
Treatment parameters
There are a number of instrumental settings that can
be varied during ESWT (Table 2). The exact relation-
ship between these settings and the effectiveness of the
treatment are often unclear, although for some settings
there is some indication as to how they may influence
effectiveness.
Energy flux densities above 0.50 mJ/mm2 should be
avoided [38, 51]. Bosch et al. [3] showed in an animal
study that EH-generated shockwaves already have a major
impact on healthy tendon tissue at an intensity of 0.14
mJ/mm2 [3].
Little is known about the optimal number of impulses in
tendinopathy, one study showed that three treatments with
500 impulses were more effective than three treatments
with 100 impulses in plantar fasciitis [30].
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High frequencies do not seem advisable as cavitation
bubbles may block the propagation of subsequent waves [10],
and the maximum generated pressure seems to drop [12].
Localization of the site that needs treatment can be
determined by means of palpation, ultrasound or radio-
graphs. The relationship between these localization meth-
ods and pathology is not always clear though [22, 28, 33].
The use of anaesthesia during ESWT seems not advis-
able as three studies comparing ESWT with and without
anaesthesia showed that treatment without anaesthesia is
more effective [16, 32, 50].
Rest seems to be important in the first phase after ESWT
treatment. Heavy physical activities are best avoided in this
phase because the tendon can bear less load shortly after
ESWT [3]. This is in line with a recent study that showed
no effect of ESWT in actively competing athletes [58].
Although research is scarce, a combination of treatments
may have a synergistic effect and lead to better results.
Two studies found better results for a combination of
ESWT and eccentric exercises than for eccentric exercises
alone [43, 48]. Further research on these topics is required.
Methodology
To prevent that natural improvement, which may be pos-
sible in the early stages of tendinopathy, is mistaken for a
treatment effect, it is important to include a placebo control
group in ESWT effectiveness studies. Furthermore, studies
should have a long enough follow-up time to discover
treatment effects, since it is known that the metabolic
turnover rate of tendon tissue is slow. These methodolog-
ical issues may also explain some of the conflicting result
found for the effectiveness of ESWT (Table 1).
Clinical effectiveness of FSWT versus RSWT
All four RCTs included in the systematic review on patellar
tendinopathy used focused shockwave devices. This may
be because radial shockwave devices have been introduced
recently. Therefore, no conclusions can be drawn with
regard to the effectiveness of RSWT for patellar tendin-
opathy. For plantar fasciitis, two RCTs have been pub-
lished that looked at the effect of RSWT [17, 24]. Both
studies found RSWT to be effective for this condition. No
other placebo controlled studies on the effectiveness of
RSWT for treating tendinopathy have been published.
There is some evidence from non-placebo controlled
studies that RSWT is effective for Achilles tendinopathy
[48, 49].
Until now, only one study has directly compared the
effectiveness of FSWT and RSWT [34], using both meth-
ods to treat plantar fasciitis, and a small difference in
favour of FSWT was found. The authors do not hypothe-
size about what may be the cause of this difference though.
Maybe FSWT was more effective because the plantar
fascia is located deep in the body (compared to other ten-
dons), so it is better reached with the waves generated by
means of FSWT, which achieve their maximal energy
within the focus. However, because RSWT also is shown to
be effective for treating plantar fasciitis [17, 24], these
waves, with a pressure field that reaches around 40 mm in
water, probably also travel far enough in tissue to reach the
affected area. It is therefore based on the present clinical
literature not possible to recommend one of the two types
of ESWT over the other.
Conclusion
Although evidence for the effectiveness of ESWT for
treating tendinopathy is inconsistent, it is used widely in
sports medicine. The present overview aimed at describing
ESWT, in particular the two types that are used: FSWT and
RSWT. Waves that are generated for FSWT and RSWT
have very different physical characteristics. The relation-
ship between these characteristics and clinical effective-
ness is unclear. Studies into the biological effects of ESWT
have mainly used FSWT, showing a number of effects of
shockwaves on biological tissue. Clinical effects of ESWT
for (patellar) tendinopathy are less clear. Reasons for this
may be the non-uniform inclusion criteria related to the
absence of a diagnostic gold standard, populations from
different pathological stages, the large number of treatment
parameters that can be varied and methodological issues.
It remains therefore questionable whether ESWT should
be recommended at all. This is probably also the case for
most other tendinopathies for which also conflicting
Table 2 Treatment parameters
Treatment parameters Description
Maximal positive pressure The maximal positive pressure
that is reached
Focal zone A 3-D ellipsoid where the
pressure is above a
certain value





Impulse frequency The number of shockwaves
that is applied/second
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findings regarding the effectiveness of ESWT have been
reported. Further research is required to determine the
value of ESWT for tendinopathy. This research should
consist of a combination of in vitro and clinical studies.
Studies with clear descriptions of study populations, diag-
nostic criteria and treatment parameters and concurrent
rehabilitation programmes/tendon loading activities are
necessary to advance research.
Clinical implications
This review provides some suggestions for the use of
ESWT in clinical practice. When ESWT is used to treat
tendinopathy, it seems best to apply it in a later stage [13],
in combination with tendon load management [29], after
other conservative options have been tried and before more
radical options like surgery are considered. Based on the
literature, low energy, a low frequency, no anaesthetics and
exercise after an initial rest period can be recommended. At
the moment, no recommendation can be given as to which
of the two types of ESWT should be used.
The introduction of RSWT next to FSWT made ESWT
more affordable and easier to administer. However, there is
no agreement in the literature as to whether ESWT is
effective for tendinopathy; hence, at the moment, there is
no information available as to which of the two methods is
preferable.
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